{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:32:22Z","timestamp":1772119942288,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11606-020-06214-1","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T14:02:28Z","timestamp":1600869748000},"page":"699-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Ecology of Antihypertensives in the United States, 1997\u20132017"],"prefix":"10.1007","volume":"36","author":[{"given":"Michael E.","family":"Johansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-7465","authenticated-orcid":false,"given":"Joshua D.","family":"Niforatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremey B.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"6214_CR1","doi-asserted-by":"crossref","unstructured":"Kirkland EB, Heincelman M, Bishu KG, et. al. Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003-2014. J Am Heart Assoc. 2018;7:e008731.","DOI":"10.1161\/JAHA.118.008731"},{"key":"6214_CR2","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death, 1999\u20132018. CDC WONDER Online Database. Atlanta, GA: Centers for Disease Control and Prevention; 2019. Accessed June 10, 2020."},{"issue":"10","key":"6214_CR3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/ajh\/hpx085","volume":"30","author":"SJ Shah","year":"2017","unstructured":"Shah SJ, Stafford RS. Current Trends of Hypertension Treatment in the United States. Am J Hypertens. 2017;30(10):1008-1014. https:\/\/doi.org\/10.1093\/ajh\/hpx085","journal-title":"Am J Hypertens."},{"key":"6214_CR4","doi-asserted-by":"publisher","unstructured":"Fuentes AV, Pineda MD, Venkata KCN. Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice. Pharm Basel Switz. 2018;6(2). https:\/\/doi.org\/10.3390\/pharmacy6020043","DOI":"10.3390\/pharmacy6020043"},{"key":"6214_CR5","doi-asserted-by":"publisher","unstructured":"Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326(7404):1423. https:\/\/doi.org\/10.1136\/bmj.326.7404.1423","DOI":"10.1136\/bmj.326.7404.1423"},{"key":"6214_CR6","doi-asserted-by":"publisher","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.006","DOI":"10.1016\/j.jacc.2017.11.006"},{"issue":"21","key":"6214_CR7","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1016\/j.jacc.2019.10.001","volume":"74","author":"DE Casey","year":"2019","unstructured":"Casey DE, Thomas RJ, Bhalla V, et al. 2019 AHA\/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2019;74(21):2661-2706. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.001","journal-title":"J Am Coll Cardiol."},{"key":"6214_CR8","doi-asserted-by":"publisher","unstructured":"Scholcoff C, Kay C, Nickoloff S, Jackson JL. Trends in Systolic Blood Pressure Control and Management in the USA, 2007 to 2016 [published online ahead of print, 2020 May 29]. J Gen Intern Med. 2020;https:\/\/doi.org\/10.1007\/s11606-020-05812-3.","DOI":"10.1007\/s11606-020-05812-3"},{"issue":"17","key":"6214_CR9","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","volume":"126","author":"Q Gu","year":"2012","unstructured":"Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126(17):2105-2114. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.096156","journal-title":"Circulation."},{"key":"6214_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40885-016-0042-0","volume":"22","author":"N Jarari","year":"2015","unstructured":"Jarari N, Rao N, Peela JR, et al. A review on prescribing patterns of antihypertensive drugs. Clin Hypertens. 2015;22:7. https:\/\/doi.org\/10.1186\/s40885-016-0042-0","journal-title":"Clin Hypertens."},{"issue":"7","key":"6214_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.15585\/mmwr.mm6707a4","volume":"67","author":"J Fang","year":"2018","unstructured":"Fang J, Gillespie C, Ayala C, Loustalot F. Prevalence of Self-Reported Hypertension and Antihypertensive Medication Use Among Adults Aged \u226518 Years - United States, 2011-2015. MMWR Morb Mortal Wkly Rep. 2018;67(7):219-224. https:\/\/doi.org\/10.15585\/mmwr.mm6707a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"6214_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3122\/jabfm.2020.01.190134","volume":"33","author":"ME Johansen","year":"2020","unstructured":"Johansen ME, Yun J, Griggs JM, Jackson EA, Richardson CR. Anti-Hypertensive Medication Combinations in the United States. J Am Board Fam Med JABFM. 2020;33(1):143-146. https:\/\/doi.org\/10.3122\/jabfm.2020.01.190134","journal-title":"J Am Board Fam Med JABFM."},{"key":"6214_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1741-7015-10-33","volume":"10","author":"A Fretheim","year":"2012","unstructured":"Fretheim A, Odgaard-Jensen J, Br\u00f8rs O, et al. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med. 2012;10:33. https:\/\/doi.org\/10.1186\/1741-7015-10-33","journal-title":"BMC Med."},{"issue":"6","key":"6214_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jdiacomp.2016.04.020","volume":"30","author":"LR Remonti","year":"2016","unstructured":"Remonti LR, Dias S, Leit\u00e3o CB, et al. Classes of antihypertensive agents and mortality in hypertensive patients with type 2 diabetes-Network meta-analysis of randomized trials. J Diabetes Complications. 2016;30(6):1192-1200. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.04.020","journal-title":"J Diabetes Complications."},{"issue":"7","key":"6214_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajh\/hpy027","volume":"31","author":"H Qi","year":"2018","unstructured":"Qi H, Liu Z, Cao H, et al. Comparative Efficacy of Antihypertensive Agents in Salt-Sensitive Hypertensive Patients: A Network Meta-Analysis. Am J Hypertens. 2018;31(7):835-846. https:\/\/doi.org\/10.1093\/ajh\/hpy027","journal-title":"Am J Hypertens."},{"key":"6214_CR16","doi-asserted-by":"publisher","first-page":"CD001841","DOI":"10.1002\/14651858.CD001841.pub3","volume":"4","author":"JM Wright","year":"2018","unstructured":"Wright JM, Musini VM, Gill R. First-line drugs for hypertension. Cochrane Database Syst Rev. 2018;4:CD001841. https:\/\/doi.org\/10.1002\/14651858.CD001841.pub3","journal-title":"Cochrane Database Syst Rev."},{"key":"6214_CR17","unstructured":"MEPS HC-201 2017 full year consolidated data file. August 2019. https:\/\/meps.ahrq.gov\/data_stats\/download_data\/pufs\/h201\/h201doc.pdf. Accessed February 7, 2020."},{"key":"6214_CR18","unstructured":"Cohen J. Design and Methods of the Medical Expenditure Panel Survey Household Component. MEPS Methodology Report No 1.; 1997. https:\/\/meps.ahrq.gov\/data_files\/publications\/mr1\/mr1.shtml. Accessed February 7, 2020."},{"issue":"4","key":"6214_CR19","first-page":"373","volume":"33","author":"JW Cohen","year":"1996","unstructured":"Cohen JW, Monheit AC, Beauregard KM, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry. 1996;33(4):373-389.","journal-title":"Inquiry."},{"issue":"7 Suppl 1","key":"6214_CR20","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1097\/MLR.0b013e3181a23e3a","volume":"47","author":"JW Cohen","year":"2009","unstructured":"Cohen JW, Cohen SB, Banthin JS. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice. Med Care. 2009;47(7 Suppl 1):S44-50. https:\/\/doi.org\/10.1097\/MLR.0b013e3181a23e3a","journal-title":"Med Care."},{"issue":"3","key":"6214_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5034\/inquiryjrnl_48.03.04","volume":"48","author":"SC Hill","year":"2011","unstructured":"Hill SC, Zuvekas SH, Zodet MW. Implications of the accuracy of MEPS prescription drug data for health services research. Inquiry. 2011;48(3):242-259. https:\/\/doi.org\/10.5034\/inquiryjrnl_48.03.04","journal-title":"Inquiry."},{"issue":"1","key":"6214_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.HYP.0000103632.19915.0E","volume":"43","author":"BL Carter","year":"2004","unstructured":"Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertens. 2004;43(1):4-9. https:\/\/doi.org\/10.1161\/01.HYP.0000103632.19915.0E","journal-title":"Hypertens."},{"issue":"5","key":"6214_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.114.05122","volume":"65","author":"RHG Olde Engberink","year":"2015","unstructured":"Olde Engberink RHG, Frenkel WJ, van den Bogaard B, Brewster LM, Vogt L, van den Born B-JH. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. Hypertens. 2015;65(5):1033-1040. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.05122","journal-title":"Hypertens."},{"issue":"5","key":"6214_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.114.05021","volume":"65","author":"GC Roush","year":"2015","unstructured":"Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertens. 2015;65(5):1041-1046. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.05021","journal-title":"Hypertens."},{"issue":"9","key":"6214_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/M16-1208","volume":"165","author":"FA Lederle","year":"2016","unstructured":"Lederle FA, Cushman WC, Ferguson RE, Brophy MT, Fiore Md LD. Chlorthalidone Versus Hydrochlorothiazide: A New Kind of Veterans Affairs Cooperative Study. Ann Intern Med. 2016;165(9):663-664. https:\/\/doi.org\/10.7326\/M16-1208","journal-title":"Ann Intern Med."},{"issue":"1","key":"6214_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.amjcard.2019.09.039","volume":"125","author":"B Abraham","year":"2020","unstructured":"Abraham B, Megaly M, Sous M, et al. Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure. Am J Cardiol. 2020;125(1):92-99. https:\/\/doi.org\/10.1016\/j.amjcard.2019.09.039","journal-title":"Am J Cardiol."},{"issue":"12","key":"6214_CR27","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.amjcard.2010.08.023","volume":"106","author":"CVS Ram","year":"2010","unstructured":"Ram CVS. Beta-blockers in hypertension. Am J Cardiol. 2010;106(12):1819-1825. https:\/\/doi.org\/10.1016\/j.amjcard.2010.08.023","journal-title":"Am J Cardiol."},{"issue":"18","key":"6214_CR28","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/archinternmed.2012.4276","volume":"172","author":"ED Parker","year":"2012","unstructured":"Parker ED, Margolis KL, Trower NK, et al. Comparative effectiveness of 2 \u03b2-blockers in hypertensive patients. Arch Intern Med. 2012;172(18):1406-1412. https:\/\/doi.org\/10.1001\/archinternmed.2012.4276","journal-title":"Arch Intern Med."},{"issue":"9446","key":"6214_CR29","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/S0140-6736(04)17355-8","volume":"364","author":"B Carlberg","year":"2004","unstructured":"Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet. 2004;364(9446):1684-1689. https:\/\/doi.org\/10.1016\/S0140-6736(04)17355-8","journal-title":"Lancet."},{"issue":"22","key":"6214_CR30","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright","year":"2015","unstructured":"SPRINT Research Group, Wright JT, Williamson JD, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103-2116. https:\/\/doi.org\/10.1056\/NEJMoa1511939","journal-title":"N Engl J Med."},{"issue":"5","key":"6214_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. https:\/\/doi.org\/10.1001\/jama.2013.284427","journal-title":"JAMA."},{"key":"6214_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fcvm.2016.00003","volume":"3","author":"MG Saklayen","year":"2016","unstructured":"Saklayen MG, Deshpande NV. Timeline of History of Hypertension Treatment. Front Cardiovasc Med. 2016;3:3. https:\/\/doi.org\/10.3389\/fcvm.2016.00003","journal-title":"Front Cardiovasc Med."},{"issue":"5","key":"6214_CR33","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/01.cir.92.5.1326","volume":"92","author":"CD Furberg","year":"1995","unstructured":"Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92(5):1326-1331. https:\/\/doi.org\/10.1161\/01.cir.92.5.1326","journal-title":"Circulation."},{"issue":"6","key":"6214_CR34","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/ajh\/hpv185","volume":"29","author":"YG Tedla","year":"2016","unstructured":"Tedla YG, Bautista LE. Drug Side Effect Symptoms and Adherence to Antihypertensive Medication. Am J Hypertens. 2016;29(6):772-779. https:\/\/doi.org\/10.1093\/ajh\/hpv185","journal-title":"Am J Hypertens."},{"issue":"11","key":"6214_CR35","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/jhh.2017.48","volume":"31","author":"DM van der Laan","year":"2017","unstructured":"van der Laan DM, Elders PJM, Boons CCLM, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017;31(11):687-694. https:\/\/doi.org\/10.1038\/jhh.2017.48","journal-title":"J Hum Hypertens."},{"issue":"1","key":"6214_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12916-018-1038-2","volume":"16","author":"R Dal-R\u00e9","year":"2018","unstructured":"Dal-R\u00e9 R, Janiaud P, Ioannidis JPA. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? BMC Med. 2018;16(1):49. https:\/\/doi.org\/10.1186\/s12916-018-1038-2","journal-title":"BMC Med."},{"issue":"2","key":"6214_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/pharmacy7020064","volume":"7","author":"Y Sahakian","year":"2019","unstructured":"Sahakian Y, Bylykbashi B, Rahman A. Prescribing Patterns of Antihypertensive Medications in US Ambulatory Care Settings. Pharmacy (Basel). 2019;7(2):64. Published 2019 Jun 14. https:\/\/doi.org\/10.3390\/pharmacy7020064.","journal-title":"Pharmacy (Basel)."},{"issue":"5","key":"6214_CR38","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/01.HYP.0000144100.29945.5e","volume":"44","author":"JL Milchak","year":"2004","unstructured":"Milchak JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension. 2004;44(5):602-608.","journal-title":"Hypertension."},{"issue":"1","key":"6214_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amjmed.2015.07.031","volume":"129","author":"A Gu","year":"2016","unstructured":"Gu A, Yue Y, Argulian E. Age Differences in Treatment and Control of Hypertension in US Physician Offices, 2003-2010: A Serial Cross-sectional Study. Am J Med. 2016;129(1):50-58. e4.","journal-title":"Am J Med."},{"issue":"2","key":"6214_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1524-6175.2007.06112.x","volume":"9","author":"G Ardery","year":"2007","unstructured":"Ardery G, Carter BL, Milchak JL, et al. Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens (Greenwich). 2007;9(2):113-119.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"13","key":"6214_CR41","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jacc.2018.01.058","volume":"71","author":"FH Messerli","year":"2018","unstructured":"Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?. J Am Coll Cardiol. 2018;71(13):1474-1482.","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"6214_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1377\/hlthaff.19.2.110","volume":"19","author":"MS Wilkes","year":"2000","unstructured":"Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff Proj Hope. 2000;19(2):110-128. https:\/\/doi.org\/10.1377\/hlthaff.19.2.110","journal-title":"Health Aff Proj Hope."},{"key":"6214_CR43","doi-asserted-by":"crossref","unstructured":"Carey C, Lieber E, Miller S. Drug Firms\u2019 Payments and Physicians\u2019 Prescribing Behavior in Medicare Part D. Natl Bur Econ Res Work Pap. February 2020:1-52.","DOI":"10.3386\/w26751"},{"issue":"2","key":"6214_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.annemergmed.2016.01.014","volume":"68","author":"W Fleischman","year":"2016","unstructured":"Fleischman W, Ross JS, Melnick ER, Newman DH, Venkatesh AK. Financial Ties Between Emergency Physicians and Industry: Insights From Open Payments Data. Ann Emerg Med. 2016;68(2):153-158. e4. https:\/\/doi.org\/10.1016\/j.annemergmed.2016.01.014","journal-title":"Ann Emerg Med"},{"key":"6214_CR45","doi-asserted-by":"publisher","unstructured":"Vijay A, Gupta R, Liu P, Dhruva SS, Shah ND, Ross JS. Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics. J Gen Intern Med. 2019. https:\/\/doi.org\/10.1007\/s11606-019-05432-6","DOI":"10.1007\/s11606-019-05432-6"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06214-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T21:59:14Z","timestamp":1632347954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06214-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["6214"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06214-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.01.20050146","asserted-by":"object"}]},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}